Upstream Bio Ownership | Who Owns Upstream Bio?
Upstream Bio Ownership Summary
Upstream Bio is owned by 78.75% institutional investors, 14.77% insiders, and 6.48% retail investors. Fmr is the largest institutional shareholder, holding 15.04% of UPB shares.
UPB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Upstream Bio | 78.75% | 14.77% | 6.48% |
| Sector | Healthcare Stocks | 42.50% | 10.81% | 46.69% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 8.09M | 15.04% | $152.11M |
| Orbimed advisors | 5.69M | 10.59% | $107.10M |
| Decheng capital | 3.29M | 6.11% | $61.80M |
| Blackrock funding, inc. /de | 2.60M | 4.84% | $48.98M |
| Enavate sciences gp | 2.46M | 4.57% | $46.27M |
| Vanguard group | 2.44M | 4.54% | $45.94M |
| Bain capital life sciences investors | 2.44M | 4.54% | $45.89M |
| Tcg crossover management | 2.12M | 3.94% | $39.82M |
| Altshuler shaham | 1.42M | 2.63% | $26.65M |
| Omega fund management | 1.36M | 2.52% | $25.51M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Enavate sciences gp | 2.46M | 14.13% | $46.27M |
| Omega fund management | 1.36M | 11.47% | $25.51M |
| Decheng capital | 3.29M | 10.78% | $61.80M |
| Bain capital life sciences investors | 2.44M | 3.05% | $45.89M |
| Orbimed advisors | 5.69M | 2.52% | $107.10M |
| Samsara biocapital | 962.15K | 2.36% | $18.10M |
| Great point partners | 300.00K | 2.33% | $5.64M |
| Tcg crossover management | 2.12M | 1.96% | $39.82M |
| Parkman healthcare partners | 843.50K | 1.66% | $15.87M |
| Vr adviser | 1.17M | 1.24% | $21.99M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| State street | 1.11M | 0.00% | 633.21K |
| Marshall wace, llp | 868.00K | 0.02% | 577.47K |
| Integral health asset management | 575.00K | 0.73% | 575.00K |
| Blackrock funding, inc. /de | 2.60M | 0.00% | 507.20K |
| Vanguard group | 2.44M | 0.00% | 271.72K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Altshuler shaham | 1.42M | 0.44% | -1.98M |
| Deep track capital, lp | - | - | -1.44M |
| Vr adviser | 1.17M | 1.24% | -1.13M |
| Tcg crossover management | 2.12M | 1.96% | -684.66K |
| Omega fund management | 1.36M | 11.47% | -680.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Integral health asset management | 575.00K | 0.73% | 575.00K | $10.82M |
| Ikarian capital | 161.11K | 0.31% | 161.11K | $3.03M |
| Summittx capital | 112.40K | 0.09% | 112.40K | $2.11M |
| Boothbay fund management | 61.30K | 0.02% | 61.30K | $1.15M |
| Exome asset management | 51.96K | 0.59% | 51.96K | $977.37K |
Sold Out
| Holder | Change |
|---|---|
| Principal securities | -12.00 |
| True wealth design | -31.00 |
| Advisor group | -42.00 |
| Physician wealth advisors | -69.00 |
| Strs ohio | -1.80K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 97 | 24.36% | 42,344,528 | -12.14% | 78 | 0.98% | 63 | 21.15% | 19 | 58.33% |
| Jun 30, 2025 | 82 | 6.49% | 48,353,677 | 6.86% | 89 | 1.26% | 55 | -28.57% | 13 | - |
| Mar 31, 2025 | 77 | - | 45,306,251 | - | 84 | - | 77 | - | - | - |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
UPB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools